Attached files
| file | filename |
|---|---|
| EX-10.1 - CRYOLIFE INC | fp0029473_ex101.htm |
| 8-K - CRYOLIFE INC | fp0029473_8k.htm |
Exhibit 99.1
FOR IMMEDIATE RELEASE
Contacts:
|
CryoLife
D. Ashley Lee
Executive Vice President, Chief Financial Officer and
Chief Operating Officer Phone: 770-419-3355 |
The Ruth Group
Zack Kubow
646-536-7020
zkubow@theruthgroup.com
|
CryoLife Completes Acquisition of JOTEC
Atlanta, GA – (December 1, 2017) – CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that it has completed its previously announced acquisition of JOTEC AG, a German-based, privately-held developer of technologically differentiated endovascular stent grafts, and cardiac and vascular surgical grafts, focused on aortic repair.
About CryoLife
Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable living tissues used in cardiac and vascular surgical procedures. CryoLife markets and sells a highly competitive product portfolio focused on treating aortic disease in more than 80 countries worldwide. For additional information about CryoLife, visit our website, www.cryolife.com.